Tag: ublituximab

Asymptomatic women at high risk for Multiple Sclerosis may have early subclinical neuroimaging abnormalities

Ublituximab lowers incidence of relapse and number of brain lesions in relapsing multiple sclerosis

byBryant Limand1 others

August 26, 2022

1. Two randomized clinical trials showed that intravenous ublituximab reduced relapse rate and the number of brain lesions in multiple ...

$#VisualAbstract GENUINE: Ublituximab and ibrutinib improved response in patients with relapsed or refractory high-risk chronic lymphocytic leukaemia compared to ibrutinib monotherapy$

#VisualAbstract GENUINE: Ublituximab and ibrutinib improved response in patients with relapsed or refractory high-risk chronic lymphocytic leukaemia compared to ibrutinib monotherapy

byKathleen Lau

March 18, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: ublituximab

Ublituximab lowers incidence of relapse and number of brain lesions in relapsing multiple sclerosis

#VisualAbstract GENUINE: Ublituximab and ibrutinib improved response in patients with relapsed or refractory high-risk chronic lymphocytic leukaemia compared to ibrutinib monotherapy

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits